英文名稱 | Glecaprevir | ABT-493 | A 1282576 |
---|---|
中文名稱 | 格來普韋 |
CAS號(hào) | 1365970-03-1 |
分子式 | C38H46F4N6O9S |
分子量 | 838.87 |
外觀 | White to off-white powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
規(guī)格 | 庫存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 | |
---|---|---|---|---|---|
暫無牌價(jià)信息,您可以發(fā)送詢價(jià),我們會(huì)盡快給你回復(fù)。 |
英文名稱 | Glecaprevir | ABT-493 | A 1282576 |
---|---|
中文名稱 | 格來普韋 |
CAS號(hào) | 1365970-03-1 |
分子式 | C38H46F4N6O9S |
分子量 | 838.87 |
外觀 | White to off-white powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Glecaprevir (previously called ABT493; A1282576;ABT-493; A-1282576;Mavyret) is a novel and potent inhibitor of thehepatitis C virus nonstructural protein 3/4A protease (HCV NS3/4A) approved as anti-HCV drug in co-formulation with an HCV NS5A inhibitor pibrentasvir.